1·After treatment with gemcitabine and CD40 antibody, the tumors shrank in 30% of the animals.
采用吉西他滨和CD 40抗体治疗后，30%的小鼠肿瘤瘤体缩小。
2·Conclusion: Neoadjuvant chemotherapy with gemcitabine and cisplatin is well tolerated and does not impair resectability of pancreatic cancer.
结论：吉西他滨联合顺铂的新辅助化疗耐受性好，并且没有破坏胰腺癌的可手术性。
3·Objective: To evaluate the curative effect, safety and adverse reaction of domestic and imported gemcitabine hydrochloride in non-small cell lung cancer (NSCLC).
目的：评价国产药与进口药盐酸吉西他滨治疗非小细胞肺癌(NSCLC)的疗效、安全性及不良反应。
4·Objective To study the antitumor effect of gemcitabine in chemotherapy with breast cancer.
目的探讨吉西他滨在乳腺癌化疗中的作用。